Gemcitabine and oxaliplatin followed by paclitaxel and carboplatin as first line therapy for patients with suboptimally debulked, advanced epithelial ovarian cancer. A phase II trial of sequential doublets. The GO-First Study
| Image |  |
|---|---|
| Description | scientific article published on 27 April 2006 |
| Author/s |
author: Desmond Yip Christopher Steer |
| Publication date | April 27, 2006 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |